DK429784D0 - Farmaceutisk praeparat til behandling af stofskiftesygdomme, dets fremstilling og anvendelse - Google Patents

Farmaceutisk praeparat til behandling af stofskiftesygdomme, dets fremstilling og anvendelse

Info

Publication number
DK429784D0
DK429784D0 DK429784A DK429784A DK429784D0 DK 429784 D0 DK429784 D0 DK 429784D0 DK 429784 A DK429784 A DK 429784A DK 429784 A DK429784 A DK 429784A DK 429784 D0 DK429784 D0 DK 429784D0
Authority
DK
Denmark
Prior art keywords
gonadoliberin
treatment
single dose
manufacture
pharmaceutical preparation
Prior art date
Application number
DK429784A
Other languages
English (en)
Other versions
DK160078B (da
DK160078C (da
DK429784A (da
Inventor
Wolfgang Koenig
Horst Neubauer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK429784D0 publication Critical patent/DK429784D0/da
Publication of DK429784A publication Critical patent/DK429784A/da
Publication of DK160078B publication Critical patent/DK160078B/da
Application granted granted Critical
Publication of DK160078C publication Critical patent/DK160078C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK429784A 1983-09-08 1984-09-07 Farmaceutisk praeparat til behandling af stofskiftesygdomme og fremgangsmaade til dets fremstilling DK160078C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833332329 DE3332329A1 (de) 1983-09-08 1983-09-08 Verwendung von gonadoliberin und gonadoliberinagonisten zur behandlung von stoffwechselerkrankungen, die auf zu geringe parathormonspiegel zurueckzufuehren sind
DE3332329 1983-09-08

Publications (4)

Publication Number Publication Date
DK429784D0 true DK429784D0 (da) 1984-09-07
DK429784A DK429784A (da) 1985-03-09
DK160078B DK160078B (da) 1991-01-28
DK160078C DK160078C (da) 1991-06-24

Family

ID=6208498

Family Applications (1)

Application Number Title Priority Date Filing Date
DK429784A DK160078C (da) 1983-09-08 1984-09-07 Farmaceutisk praeparat til behandling af stofskiftesygdomme og fremgangsmaade til dets fremstilling

Country Status (8)

Country Link
EP (1) EP0137294B1 (da)
JP (1) JPS6072824A (da)
AT (1) ATE42467T1 (da)
AU (1) AU567183B2 (da)
DE (2) DE3332329A1 (da)
DK (1) DK160078C (da)
GR (1) GR80312B (da)
ZA (1) ZA847047B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3414595A1 (de) * 1984-04-18 1985-10-31 Hoechst Ag, 6230 Frankfurt Verwendung von gonadoliberin und gonadoliberinagonisten zur behandlung klimakterischer beschwerden
FR2623912B1 (fr) * 1987-11-27 1990-03-23 Lacroix E Tous Artifices Detecteur radioaltimetrique et fusee de proximite equipee d'un tel detecteur

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2450109B1 (fr) * 1977-11-08 1986-03-28 Roussel Uclaf Nouvelle methode de traitement utilisant la lh-rh, ou des agonistes
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes

Also Published As

Publication number Publication date
ZA847047B (en) 1985-04-24
DE3477882D1 (en) 1989-06-01
GR80312B (en) 1985-01-02
EP0137294B1 (de) 1989-04-26
DK160078B (da) 1991-01-28
DK160078C (da) 1991-06-24
EP0137294A2 (de) 1985-04-17
DK429784A (da) 1985-03-09
AU567183B2 (en) 1987-11-12
DE3332329A1 (de) 1985-03-28
ATE42467T1 (de) 1989-05-15
EP0137294A3 (en) 1987-04-15
JPS6072824A (ja) 1985-04-24
AU3283984A (en) 1985-03-14

Similar Documents

Publication Publication Date Title
IL83363A (en) Use of indol-3-yl-carboxylic acid endo-8-methyl-8-aza- bicyclo (3,2,1) oct-3-yl ester for the preparation of psycho-active pharmaceutical compositions suitable for the treatment of stress- related psychiatric disorders or for increasing vigilance
GR880300058T1 (en) Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
EP0508488A3 (en) Use of inositol triphosphate for the treatment of diseases associated with metal intoxications
AU588202B2 (en) Dosage form for delivering acid sensitive beneficial agent
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
IT8567263A0 (it) Dispositivo di erogazione per la somministrazione controllata di un agente benefico particolamente di un farmaco a ruminanti
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
PT615754E (pt) Formas solidas de administracao oral de libertacao controlada flupertina
IL91949A (en) Dispersible formulation containing the free acid form of diclofenac
ES486277A1 (es) Procedimiento para la obtencion de pasta sintetica para pro-tesis y reparaciones dentales, a base de metacrilatos
WO1987004926A3 (en) Method of modifying the lipid structure of cell membranes and pharmaceutical compositions for use therein
GR3025792T3 (en) Use of phosphonates for the treatment of osteoporosis.
ZA892877B (en) Azelastine-containing medicaments with controlled release of the active substance
SE415367B (sv) Forfarande for limning med resorcinolhartslim med anvendning av en uppslamning av paraformaldehyd som herdare samt herdarkomposition for anvendning vid settet
ZA87216B (en) A pharmaceutical composition with sustained release of the active component and a process for the preparation thereof
DK429784A (da) Farmaceutisk praeparat til behandling af stofskiftesygdomme, dets fremstilling og anvendelse
AU2908389A (en) Device for administering medicaments by atomization in intubated or tracheotomized patients
ES8308317A1 (es) Procedimiento de preparacion de nuevos derivados de 2-fenilmorfolina.
GR3007347T3 (da)
JPS55122715A (en) Antidiabetic agent
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
DE3568944D1 (en) Pharmaceutical composition for oral administration containing, on the one hand, as active principle the 9-alpha,11-beta dichloro-16-alpha methyl 21-oxycarbonyldicyclohexylmethyloxy pregna-1,4-diene 3,20-dione and, on the other hand, an inert pharmaceutical excipient which is able to permit the activity of the product in the rectum or in the colon and the utilization of the active principle in the preparation of such a pharmaceutical composition
JPS5626819A (en) Preventive for hypoimmunity
SE8705035D0 (sv) Anvendning av alkylglycerol
DK620989A (da) Anvendelse af et prostaglandin af e-typen i kombination med cyclosporin til fremstilling af et farmaceutisk praeparat